NEUROMED PHARMACEUTICALS APPOINTS FORMER PFIZER SENIOR MANAGER TO EXECUTIVE TEAM

A A

Neuromed Pharmaceuticals, a biopharmaceutical company developing next-generation chronic pain drugs, today announced the appointment of Dr. Stephen Arneric to its executive team. Dr. Arneric will be Vice President of Research and Preclinical Development responsible for the oversight of the Neuromed's discovery and preclinical operations.
CNW Group